Lates News
Belgian biopharmaceutical company UCB announced on Friday that it has reached a final agreement to acquire Neurona Therapeutics, with a total transaction value of up to $1.15 billion, aiming to incorporate its leading neural stem cell therapy NRTX-1001 into its epilepsy product portfolio.
Latest

